La Drug and Food Administration (FDA) and the Centers for Disease Control and Prevention (CDC), the main sanitary authorities of the United States, recommend a “pause” in the use of the Johnson & Johnson against COVID-19. The reason: temor a que see causing blood clots.
La FDA and the CDC are evaluating the “Potential Importance” of six cases reported by common coagular tumors in patients receiving the injection. Alert the public the Drug and Food Administration found on his official Twitter account.
“We recommend a break in the use of this vacancy for precaution”.
Se lee en parte del mensaje.
The controller informs that, until the moon, is habían administered more than 6.8 million of the Johnson & Johnson vaccine dose in United States.
The CDC and the FDA are reviewing data from six cases reported in the United States of a rare blood type and only produced by individuals after receiving the vaccine. At the moment, these adverse events are extremely rare ”.
The FDA wrote on Twitter.
The agency affirms that pide is an interruption to allow the medical attention providers that obtengan “The only treatment required against this type of blood clot”.
Ante the situation, the CDC convenes a committee to assess the markets at the end of ‘Review’ a fund these cases and evaluate its potential importance. The FDA is reviewing this analysis, and we are also investigating these cases ”.
The declaration is produced after the regulator of medicines of the European Union dijera que también est revisend possible cases of blood clots in persons receiving the Johnson & Johnson vacuna.
